Report cover image

DexCom Inc (DXCM) - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Sep 22, 2025
Length 53 Pages
SKU # GBDT20417074

Description

Summary

Dexcom Inc (Dexcom) is a medical device company focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems. Its major products include the Dexcom G7 and G6 integrated CGM systems, Dexcom Share remote monitoring system, Dexcom Real-Time API, Dexcom ONE CGM system, associated software, mobile apps, and Stelo Glucose Biosensor. The company also provides Dexcom Care training to users of the CGM system and other support services. It offers products to endocrinologists, physicians, diabetes educators, and others in the US, Austria, Canada, Germany, Switzerland, and the UK, and through distributors in Australia, the US, New Zealand, and other countries in Asia, Europe, Africa, Latin America, and the Middle East. Dexcom is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company DexCom Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

53 Pages
DexCom Inc Company Overview
DexCom Inc Company Snapshot
DexCom Inc Pipeline Products and Ongoing Clinical Trials Overview
DexCom Inc – Pipeline Analysis Overview
Business Description
DexCom Inc - Key Facts
DexCom Inc - Major Products and Services
DexCom Inc Pipeline Products by Development Stage
DexCom Inc Ongoing Clinical Trials by Trial Status
DexCom Inc Pipeline Products Overview
ABC4D
ABC4D Product Overview
ACHIEVE mHealth App
ACHIEVE mHealth App Product Overview
ACHIEVE mHealth App Clinical Trial
DexCom CGM With Accu-Chek Insulin Delivery System
DexCom CGM With Accu-Chek Insulin Delivery System Product Overview
Dexcom G7 CGM System
Dexcom G7 CGM System Product Overview
Dexcom G7 CGM System Clinical Trial
Dexcom Hospital Continuous Glucose Monitoring System
Dexcom Hospital Continuous Glucose Monitoring System Product Overview
First-Gen Verily Sensor
First-Gen Verily Sensor Product Overview
inControl
inControl Product Overview
Touchscreen Receiver
Touchscreen Receiver Product Overview
DexCom Inc - Key Competitors
DexCom Inc - Key Employees
DexCom Inc - Key Employee Biographies
DexCom Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
DexCom Inc, Recent Developments
Sep 16, 2025: Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025
Sep 15, 2025: Continuous Glucose Monitor Apps Correction: Dexcom Issues Correction for G7 Apps and ONE+ Apps due to a Software Design Error That Does Not Alert Users of Unexpected Sensor Failure
Jul 30, 2025: Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program
Jul 28, 2025: Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
Jul 23, 2025: Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration
Jul 17, 2025: Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
Jul 17, 2025: Continuous Glucose Monitor Receiver Recall: Dexcom Removes Certain Dexcom G6, G7, ONE, and ONE+ Receivers Due to Speaker Malfunction That May Cause Missed Alerts for Dangerous Blood Sugar Levels
Jul 01, 2025: DexCom Second Quarter 2025 Earnings Release Conference Call
Apr 22, 2025: DexCom Receives FDA 510(k) Clearance for Dexcom G7 15 Day Continuous Glucose Monitoring System
Apr 10, 2025: Dexcom G7 15 Day Receives FDA Clearance: The Longest Lasting Wearable and Most Accurate CGM System
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
DexCom Inc Pipeline Products and Ongoing Clinical Trials Overview
DexCom Inc Pipeline Products by Equipment Type
DexCom Inc Pipeline Products by Indication
DexCom Inc Ongoing Clinical Trials by Trial Status
DexCom Inc, Key Facts
DexCom Inc, Major Products and Services
DexCom Inc Number of Pipeline Products by Development Stage
DexCom Inc Pipeline Products Summary by Development Stage
DexCom Inc Ongoing Clinical Trials by Trial Status
DexCom Inc Ongoing Clinical Trials Summary
ABC4D - Product Status
ABC4D - Product Description
ACHIEVE mHealth App - Product Status
ACHIEVE mHealth App - Product Description
ACHIEVE mHealth App - ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
DexCom CGM With Accu-Chek Insulin Delivery System - Product Status
DexCom CGM With Accu-Chek Insulin Delivery System - Product Description
Dexcom G7 CGM System - Product Status
Dexcom G7 CGM System - Product Description
Dexcom G7 CGM System - A Randomized Controlled Trial Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects with Type 1 Diabetes
Dexcom G7 CGM System - Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery
Dexcom G7 CGM System - Assessing the Safety, Performance, and User Experience of the Tandem Mobi Automated Insulin Delivery System Among Young Competitive Athletes in Real-world Settings.
Dexcom G7 CGM System - CGMs for All: Studying the Impact of Expanding CGM Access
Dexcom G7 CGM System - Comparison of Continous Glucose Monitor and OGTT As a Screen for Cystic Fibrosis Related Diabetes and Impaired Glucose Tolerance
Dexcom G7 CGM System - Comparison of Continuous Glucose Monitoring and Point-of-Care Measurements on the Intensive Care Unit: An Exploratory Study
Dexcom G7 CGM System - Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Dexcom G7 CGM System - Continuous Glucose Monitoring in Haemodialysis and Peritoneal Dialysis Patients with Type 1 and Type 2 Diabetes
Dexcom G7 CGM System - Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass
Dexcom G7 CGM System - Continuous Glucose Monitoring in Treatment of Postprandial Hypoglycemia After Gastric Bypass Surgery: The HypoSurge Randomized Clinical Trial
Dexcom G7 CGM System - Continuous Intraoperative Glucose Monitoring: A Pilot Study
Dexcom G7 CGM System - Dexcom Continuous Glucose Monitoring System Use in a Real-World, Global Registry
Dexcom G7 CGM System - Early Investigation of Glucose Monitoring After Gestational Diabetes (ENGAGED): Utility and Acceptability of Continuous Glucose Monitoring in the Early Postpartum Period After Gestational Diabetes Mellitus
Dexcom G7 CGM System - Effect of Continuous Interstitial Glucose Monitoring on Glycaemic Targets and Clinical Outcomes in Critically Ill
Dexcom G7 CGM System - Effect of Switching From Intermittently Scanned Continuous Glucose Monitoring to Real-time Continuous Glucose Monitoring on Glycemic Outcomes in Adults With Type 2 Diabetes
Dexcom G7 CGM System - Efficacy of Early Notification of Low and high Inpatient glycaemia with a Glucose Hospital Telemetry System: the ENLIGHTS RCT
Dexcom G7 CGM System - Establishing a Sustainable Diabetes Care Management Program Using Continuous Glucose Monitors and Remote Patient Monitoring for Underserved Populations in Safety Net Clinics
Dexcom G7 CGM System - Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7 in a Real-World Community Ambulatory Health Setting
Dexcom G7 CGM System - Pregnancy and Postpartum Continuous Glucose Monitoring in Gestational Diabetes
Dexcom G7 CGM System - Randomized Controlled Trial Using Remote Monitoring With an Automated Patient Engagement System and a Self-Monitoring Program With Continuous Glucose Monitors to Address Health Disparities in Type 2 Diabetes
Dexcom G7 CGM System - The Effect of Continuous Glucose Monitoring with Real-time Alerts on Glycaemic Control in Surgical Patients with Diabetes: a Randomised, Clinical Multicentre Trial
Dexcom G7 CGM System - The Use of Continuous Glucose Monitoring with Patients Undergoing a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State
Dexcom G7 CGM System - Trends in Continuous Glucose Monitoring Measures of Glycaemic Variability in Australian Children with Early Stage T1D (TRACE-T1D study)
Dexcom G7 CGM System - Validation of the Accuracy of Continuous Glucose Monitoring Using the Dexcom G7 in Patients with Diabetes in Situations with Circulatory Impairment. a Prospective Observational Study
Dexcom Hospital Continuous Glucose Monitoring System - Product Status
Dexcom Hospital Continuous Glucose Monitoring System - Product Description
First-Gen Verily Sensor - Product Status
First-Gen Verily Sensor - Product Description
inControl - Product Status
inControl - Product Description
Touchscreen Receiver - Product Status
Touchscreen Receiver - Product Description
DexCom Inc, Key Employees
DexCom Inc, Key Employee Biographies
DexCom Inc, Subsidiaries
Glossary
List of Figures
DexCom Inc Pipeline Products by Equipment Type
DexCom Inc Pipeline Products by Development Stage
DexCom Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us